Impact BioMedical Inc.

AMEX: IBO · Real-Time Price · USD
0.58
0.01 (2.29%)
At close: Aug 15, 2025, 3:59 PM
0.56
-1.77%
After-hours: Aug 15, 2025, 06:43 PM EDT

Impact BioMedical Balance Sheet Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
2M 1K 726.05K 142.2K
Short-Term Investments
n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
17K n/a n/a 42.93K
Receivables
184K 331K 231K 113.5K
Inventory
n/a n/a n/a n/a
Other Current Assets
n/a n/a n/a n/a
Total Current Assets
2.45M 332K 1.02M 901.54K
Property-Plant & Equipment
17K 287K 5.3M 3.05M
Goodwill & Intangibles
17.81M 44.01M n/a n/a
Total Long-Term Assets
17.84M 44.3M 5.3M 3.09M
Total Assets
20.29M 44.63M 6.32M 3.99M
Account Payables
713K 832K 171.79K 295.92K
Deferred Revenue
n/a n/a 165.9K 290.89K
Short-Term Debt
8.88M 12.07M n/a 350K
Other Current Liabilities
n/a n/a 299.3K 51.06K
Total Current Liabilities
9.79M 13.14M 636.99K 987.87K
Long-Term Debt
n/a n/a 1.74M 60K
Other Long-Term Liabilities
n/a n/a n/a n/a
Total Long-Term Liabilities
3.27M 3.23M 1.74M 60K
Total Liabilities
13.05M 16.37M 2.37M 1.05M
Total Debt
8.88M 12.07M 1.74M 410K
Common Stock
11K 10K 22.8M 13.79M
Retained Earnings
-37.67M -12.96M -22.74M -12.25M
Comprehensive Income
n/a n/a 3.88M 1.4M
Shareholders Equity
4.26M 25.22M 3.94M 2.94M
Total Investments
n/a n/a n/a n/a